Researchers develop database to help accelerate drug discovery

Sep 15, 2010

Researchers from Mount Sinai School of Medicine have developed a new computational method that will help streamline the analysis of gene expression experiments and provide scientists with a better mechanistic understanding of the differences between diseased and normal cells. The new database and software, called ChIP Enrichment Analysis (ChEA), will revolutionize how researchers identify drug targets and biomarkers.

Researchers can find the tool online at http://amp.pharm.mssm.edu/lib/chea.jsp. The data are published in the September 15th issue of Bioinformatics.

Until ChEA was developed, there was no centralized database that integrated results from ChIP-seq and ChIP-chip experiments—two types of experiments used to identify how proteins called potentially regulate all genes in humans and mice. The data that results from these types of experiments is substantial and computational biologists have struggled with how to integrate them. Led by Avi Ma'ayan, PhD, Assistant Professor, Pharmacology and Systems Therapeutics, a team at Mount Sinai integrated the results from these experiments, collecting data from more than 100 proteins that bind DNA to regulate gene expression, called transcription factors, into one database.

"Using ChEA, we were able to link these transcription factors to the genes they regulate for the first time," said Dr. Ma'ayan. "Our program allows researchers to identify which proteins are likely responsible for that may cause disease. Using our database, researchers will be able to better identify drug targets."

Dr. Ma'ayan's team tested ChEA in several case studies. One case study looked at two independent publications that found signature sets of genes that indicate whether a was benign or malignant. Both studies came up with lists of genes that were biomarkers of each tumor type. However, the list uncovered in one study did not match the list in the other study; in fact, there was very little overlap in the biomarkers discovered in each study. However, when Dr. Ma'ayan entered the two lists into ChEA, he determined that the genes on both lists have the same regulatory , which determines the aberrant expression of these biomarker .

"Our reanalysis of these two publications verifies the usefulness of this software and database in gaining a better mechanistic understanding of the role transcription factors play in controlling , and subsequently, the development of disease," said Dr. Ma'ayan.

Explore further: Doubt cast over air pollution link between childhood leukemia and power lines

Provided by The Mount Sinai Hospital

not rated yet
add to favorites email to friend print save as pdf

Related Stories

'Moonlighting' molecules discovered

Oct 29, 2009

Since the completion of the human genome sequence, a question has baffled researchers studying gene control: How is it that humans, being far more complex than the lowly yeast, do not proportionally contain in our genome ...

Researchers discover new way diseases develop

Jul 08, 2010

Researchers from Mount Sinai School of Medicine have identified a previously unknown mechanism by which cells direct gene expression, the process by which information from a gene is used to direct the physical and behavioral ...

Putting microRNAs on the stem cell map

Aug 07, 2008

Embryonic stem cells are always facing a choice—either to self-renew or begin morphing into another type of cell altogether. It's a tricky choice, governed by complex gene regulatory circuitry driven by a handful of key ...

Cocaine-linked genes enhance behavioral effects of addiction

May 13, 2009

New research sheds light on how cocaine regulates gene expression in a crucial reward region of the brain to elicit long-lasting changes in behavior. The study, published by Cell Press in the May 14th issue of the journal ...

Recommended for you

Unlocking the secrets of pulmonary hypertension

2 hours ago

A UAlberta team has discovered that a protein that plays a critical role in metabolism, the process by which the cell generates energy from foods, is important for the development of pulmonary hypertension, a deadly disease.

New molecule sneaks medicines across the blood/brain barrier

7 hours ago

Delivering life-saving drugs across the blood-brain barrier (BBB) might become a little easier thanks to a new report published in the November 2014 issue of The FASEB Journal. In the report, scientists describe an antibo ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.